Form 8-K - Current report:
SEC Accession No. 0001645113-25-000003
Filing Date
2025-02-27
Accepted
2025-02-27 07:02:06
Documents
14
Period of Report
2025-02-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nvcr-20250227.htm   iXBRL 8-K 24697
2 EX-99.1 nvcr-20241231xpr.htm EX-99.1 181593
  Complete submission text file 0001645113-25-000003.txt   348241

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nvcr-20250227.xsd EX-101.SCH 1882
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nvcr-20250227_lab.xml EX-101.LAB 21801
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nvcr-20250227_pre.xml EX-101.PRE 12579
16 EXTRACTED XBRL INSTANCE DOCUMENT nvcr-20250227_htm.xml XML 2804
Mailing Address NO. 4 THE FORUM GRENVILLE STREET ST. HELIER Y9 JE2 4UF
Business Address NO. 4 THE FORUM GRENVILLE STREET ST. HELIER Y9 JE2 4UF 44 (0)15 3475 6700
NovoCure Ltd (Filer) CIK: 0001645113 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37565 | Film No.: 25672932
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)